LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-46.16M
Near historical average
Percentile
P67
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-47.13M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-46.16M | +22.9% |
| 2024 | $-59.86M | +0.9% |
| 2023 | $-60.41M | +36.1% |
| 2022 | $-94.57M | -61.4% |
| 2021 | $-58.59M | -470.7% |
| 2020 | $-10.27M | -53931.6% |
| 2019 | $-19000.00 | - |